Psoriasis in children and adolescents: A nationwide physician survey on the healthcare situation in Germany;Psoriasis im Kindes- und Jugendalter: Eine bundesweite Ärztebefragung zur Versorgungssituation in Deutschland

Hautarzt

Volumn 63, Issue 10, 2012, Pages 801-807

  Matusiewicz, D ^a   Korber A ^b   Schadendorf, D ^b   Wasem, J ^a   Neumann, A ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Adolescents; Children; Healthcare situation; Primary data acquisition; Psoriasis

Indexed keywords

ARTICLE; CHILD HEALTH CARE; CONTROLLED STUDY; DERMATOLOGIST; GERMANY; HEALTH CARE SURVEY; HUMAN; PEDIATRICIAN; PSORIASIS; SYSTEMIC THERAPY; TOPICAL TREATMENT;

ADOLESCENT; CHILD; DATA COLLECTION; DELIVERY OF HEALTH CARE; FEMALE; GERMANY; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PREVALENCE; PSORIASIS; RISK FACTORS; YOUNG ADULT;

EID: 84867879114     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-012-2431-y     Document Type: Article

References (11)

1. Altobelli E, Petrocelli R, Marziliano C, et al. (2007) Family history of psoriasis and age at disease onset in Italian patients with psoriasis. Br J Dermatol 156:1400-1401
2. Augustin M, Glaeske G, Radtke MA, et al. (2009) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633-636
3. Bundesärztekammer (2010) Berufstätige Ärztinnen und Ärzte nach Arztgruppen zum 31.12.2009. Online-Publikation; http://www.bundesaerztekammer.de/page.asp?his=0.3.8175.8177
4. Howard R, Tsuchiya A (1998) Adult skin disease in the pediatric patient. Dermatol Clin 16(3):593-608
5. Kundakci N, Türsen Ü, Babiker MA, Gürgey E (2002) The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 41:220-224
6. Langley RG, Paller AS, Hebert AA, et al. (2011) Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol 64(1):64-70
7. Nanda A, Al-Fouzan AS, El-Kashlan M, et al. (2000) Salient features and HLA markers of childhood psoriasis in Kuwait. Clin Exp Dermatol 25:147-151
8. Nast A, Boehnecke WH, Mrowietz U, et al. (2011) S3 -Leitlinie zur Therapie der Psoriasis vulgaris. http://www.awmf.org/uploads/tx-szleitlinien/ 013-001l-S3-Psoriasis-vulgaris-Therapie-01.pdf
9. Paller AS, Siegfried EC, Eichenfield LF, et al. (2010) Long-term etanercept in pediatric patients with plaque psoriasis. J Am Acad Dermatol 63(5):762-768
10. Raychaudhuri SP, Gross J (2000) A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 17:174-178
11. Schäfer I, Rustenbach SJ, Radtke M, et al. (2011) Epidemiologie der Psoriasis in Deutschland -Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung. Gesundheitswesen 73:308-313